Thursday, 30 November 2017

Concept of generic drugs and its ingredients


A generic drug is a pharmaceutical creation, generally proposed to be interchangeable with a brand product, manufactured without a license from the innovation company and marketed after the patent expiration date or other exclusive rights.

Generic products can also be termed as multisource products. And you will often see the chemical name of a drug termed as "generic" or "non-proprietary" name, which has been described could lead to confusion among consumers who can only know their prescription only from the brand name.

The active pharmaceutical ingredient (API)

The drugs that have an API enable generic drugs to be promoted because when we compare generics, the API is the same. Instead, consider the scenario of an herbal remedy. A single 100 mg raw herb tablet could contain hundreds of different chemicals. If there are no known APIs or standardized active ingredients, we may not be able distinguish between brands or assume that clinical trials with a brand are relevant to any other product because we have no idea which ingredient is actually producing an effect and if any other version has the same ingredient (or a combination of ingredients).




Bioavailability

Most dosage forms (e.g. tablets and capsules) are designed to provide the API to the action site. Unless it is a drug that acts directly on the lining of the gastrointestinal tract, we rely on the circulatory system to bring the drug to the site of action in the body. Bioavailability is the amount of drug that, once ingested, reaches the bloodstream.

Bioequivalence

Two products are said to be bioequivalent when the rate and extent of absorption of the generic drug do not show a significant difference with respect to the rate and extent of absorption of the brand name drug when administered at the same dose under similar experimental conditions.

Conclusion

The science of generic bioequivalence assessments has been implemented in most countries for over 20 years with a proven track record of therapeutic equivalence. These assessment methods have been so successful in setting generic drug standards that are broadly consistent across all major drug regulators worldwide. Both healthcare professionals and customers can be reassured that generic drugs approved under this regulatory guidance are effectively bioequivalent and, therefore, interchangeable with branded products.

About Us


Mediklik is an online platform for this service where you can book an online medical appointment in simple ways. If you are looking for a specialist, you can consult a doctor online with the help of Mediklik. Here you can chat with an online physician and find solutions to your health problems.



Tuesday, 28 November 2017

Reasons a Personal Health Record Can Reduce Your Medical Expense


The use of a personal health record can reduce health costs because much of the money spent on health care is used to acquire the data needed for diagnosis and appropriate treatment. With the adoption of the Health Care Reform Act that will expand medical coverage to 32 million people by 2019, more patients will establish new doctor/patient relationships and the flow of health information will probably increase exponentially.

Although in recent years, physicians have been striving to purchase and use electronic health record programs for managing patient health data in the hope of having a centralized repository of patient’s health data. Due to differences in practice and documentation styles, a central database would not contain all the updated data in real time to meet the health needs of individual patients in all health care settings. Therefore, the best warehouse for your health information is your own personal health record.

A scenario illustrating the cost of producing and exchanging medical data is the initial visit of a new patient to establish a doctor/patient relationship. A doctor who sees a patient at a first meeting needs historical information that is often missing because the patient is not informed and/or because previous treatment records have not been requested, requested but not received or requested and received but illegible. The new physician will often need approximate dates of diagnoses, approximate dates, and results of previous tests, as well as approximate dates of hospitalizations with some details of care provided. If this information is not available, some doctors will order tests that he or she might not otherwise order if the necessary information was available at the time of the patient's visit. The net result is an extra expense for the patient or at the very least another cog in the wheel of increasing health care costs.

Many diagnoses and treatment plans are based on subjective information, that is, information transmitted by the patient. For example, in the assessment of chest pain, a physician usually needs to know when and how the pain started, the location of the pain, the frequency of the pain, the duration of the pain, the intensity of the pain, the quality of the pain (cramps, burns, tingling, etc.), which makes it better, which brings it, which makes it worse, and other symptoms associated with pain before deciding to admit the patient to the hospital to rule out a heart attack or whether to treat the patient for acid reflux outside the hospital. However, on a number of occasions, due to poor preparation and/or nervousness, patients feel put on the spot when asked about their symptoms and conditions. By recording information about your health conditions and symptoms to be discussed during a future visit to the doctor, a patient is better prepared to visit with useful information that can reduce expenses by minimizing excessive dependence on tests. In addition, the information recorded is likely to be more accurate than information that has not been recorded and therefore more likely to maximize the quality of care received.

A personal health record could also reduce health expenses during follow-up or illness visits, as the well-designed software allows the patient to create pre-visit notes and diary notes on new problems and established problems, which can be brought to the doctor during a visit. In addition, by updating your health data in the personal health record, you will be better prepared to answer questions that will be presented at a doctor's visit in future.

About Us


Mediklik is a great online platform whether it is for getting an online health consultation, share your health records online, find the right specialist for your condition or know correct and upright information about diseases, medicines, surgical procedures and first-aid. This platform provides the one-stop platform for all your health.





Monday, 27 November 2017

Telemedicine in India: Unimaginable Benefits both For Doctors and Patients


One should not take the literal meaning of the word "telemedicine" because it is much vast than just talking to the doctor over the phone. The rise of various technologies at the end of the 20th century allowed people to connect with each other like never before, and the medical industry was one of the main beneficiaries. Studies to date have divided the field of telemedicine into three broad categories: "store-based medicine and advanced medicine", "remote monitoring" and "real-time interactive telemedicine". The storage time and the advanced telemedicine category imply that a patient sends this file to the doctor, who is then viewed offline at the appropriate time of the doctor. Remote monitoring is a kind of self-monitoring where the doctor simply recommends the devices to be used and the patient uses them himself. Real-time interactive telemedicine is the most common type where the doctor and the patient are face-to-face to discuss health and well-being.

The use of telemedicine in India is at an early stage but is expected to increase rapidly in the coming years as more people become aware of its applications. In a country as densely populated as India, this service is of the utmost importance, because the doctor-patient relationship in this country is sufficient to make his health uncertain. According to a report published in 2000 by WHO, India ranks 112th out of 190 countries with a good physician / patient ratio. Now, the increase in the number of doctors cannot come in a single day. A country must make optimal use of its resources and this is where "telemedicine" takes center stage.



The Apollo Hospital Group is the pioneer to take the first steps towards the widespread use of telemedicine in India. They started a project in a secondary hospital in this area in a village in Andhra and today this village has its own state-of-the-art video conferencing system thanks to the support provided by ISRO. This shows that telemedicine in India has a future if people and government are committed to it with sincerity and dedication.

In an ideal world, every man, regardless of age, caste or religion, receives world-class health care. In the real world, however, the thought of something like this sounds ridiculous. But the rise of telemedicine may have allowed people to realize this part of an ideal world and, in turn, to make this world a better place. There are many examples in the past to prove it.

About Us




MediKlik is a Doctor-patient engagement platform to enable smooth communication between doctor and patient by offering state-of-the-art healthcare facilities like online health records, remote patient monitoring, share your health profile with doctor and search/consult nearby specialists.


Mediklik-Apka Health Buddy


Tuesday, 21 November 2017

Hope for Type 1 Diabetes Patient: Stem Cells Could Be the Cure

According to the latest advances, stem cells generated in Advanced National US Laboratory, in collaboration with the International Space Station, have shown promising progress in creating insulin-producing beta cells, useful as a potential treatment for type 1 diabetes. Scientists are also interested in finding ways to cure silent sugar disease, through the application of regenerative science; either by producing beta cells or by creating an environment through stem cells that will indirectly support beta cell production. In both cases, stem cells are identified as the major players.
Diabetes is a devastating autoimmune metabolic disease that affects millions of people around the world. It is categorically distinguished into two main types, 1 & 2; according to their functional attributes. As in, type 1 diabetes is often associated with aberrant destruction of insulin-producing beta cells, causing the accumulation of sugar molecules in the blood, due to the unavailability of its transporter to the cell, the insulin hormone. Whereas, type 2 diabetes, is associated with insulin resistance due to which various important organs of the body, do not respond to the action of insulin; adding to the gradual decline in functional production of insulin, through beta cells. With conventional medications, the only treatment proposed to overcome the problem is steroidal anti-inflammatory drugs to reduce beta and/or insulin loss, as well as a sugar-free diet to maintain blood sugar levels in the body.

However, researchers have long been struggling to find an alternative and cost-effective cellular solution as a potential strategy for treating diabetes, whether type 1 or type 2. As a result, they have developed a keen interest in unlocking the mysteries of diabetes. As well as the exploration of stem cell therapies. It has been apparent that stem cells are an appropriate viable option for reversing cell damage associated with a particular cell type. Theoretically, stem cells have been found to respond to molecular signals, in the local environment by the differentiation of desired beta cells.


Stem cells are tiny parent cells, with the ability to differentiate into several types of cells when subjected to appropriate signaling pathways. This potential stem cell capacity has been exploited by medical science to treat diabetes. These stem cells have been found dormant in various autologous tissues of the body, which can be isolated and enriched in greater numbers in a controlled state to prepare them for local injection at the site of the lesion. It has been evident through various experiments honoring the autologous application of stem cells to be used effectively for their differentiation into insulin-producing beta cells, regulating regulatory immune cells to prevent immune tissue destruction and promoting a favorable microenvironment to stimulate residential stem cells. To be active against self-differentiation. In this regard, numerous clinical studies have been conducted to evaluate the clinical safety and efficacy of stem cell treatment for type 1 diabetes in achieving effective therapeutic outcomes.
Although, more and more mechanism is on the way to standardize the results of effective treatment to cure silent metabolic disorders, such as type 1 diabetes; with current knowledge and technological establishment, it has proved to be the best option possible.
To learn more about the treatment of diabetes, visit our website: Mediklik

About Us


Mediklik is an online platform for this service where you can book an online medical appointment in simple ways. If you are looking for a specialist, you can consult a doctor online with the help of Mediklik. Here you can chat with an online physician and find solutions to your health problems.




Tips on Preventing Psoriasis Flare Ups

Psoriasis is considered one of the most common skin conditions in the world. Millions of people are affected by this condition...